METHYLHEXAHYDROPHTHALIC ACID ANHYDRIDE | ICSC: 1644 (October 2006) |
MHHPA Hexahydromethylphthalic acid anhydride 1,3-Isobenzofurandione, hexahydromethyl- |
CAS #: 25550-51-0 |
EC Number: 247-094-1 |
ACUTE HAZARDS | PREVENTION | FIRE FIGHTING | |
---|---|---|---|
FIRE & EXPLOSION | Combustible. Gives off irritating or toxic fumes (or gases) in a fire. | NO open flames. | Use water spray, foam, powder, carbon dioxide. |
AVOID ALL CONTACT! | |||
---|---|---|---|
SYMPTOMS | PREVENTION | FIRST AID | |
Inhalation | Cough. Wheezing. | Use ventilation, local exhaust or breathing protection. | Fresh air, rest. Refer for medical attention. |
Skin | Redness. | Protective gloves. Protective clothing. | Remove contaminated clothes. Rinse and then wash skin with water and soap. |
Eyes | Redness. Pain. | Wear face shield or eye protection in combination with breathing protection. | First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention. |
Ingestion | Abdominal pain. Diarrhoea. | Do not eat, drink, or smoke during work. | Rinse mouth. Refer for medical attention . |
SPILLAGE DISPOSAL | CLASSIFICATION & LABELLING |
---|---|
Personal protection: complete protective clothing including self-contained breathing apparatus. Collect leaking and spilled liquid in covered containers as far as possible. |
According to UN GHS Criteria DANGER
May cause allergic skin reactionCauses serious eye irritation Causes skin irritation Transportation |
STORAGE | |
Separated from food and feedstuffs. Dry. | |
PACKAGING | |
METHYLHEXAHYDROPHTHALIC ACID ANHYDRIDE | ICSC: 1644 |
PHYSICAL & CHEMICAL INFORMATION | |
---|---|
Physical State; Appearance
Physical dangers
Chemical dangers
|
Formula: C9H12O3 |
EXPOSURE & HEALTH EFFECTS | |
---|---|
Routes of exposure
Effects of short-term exposure
|
Inhalation risk
Effects of long-term or repeated exposure
|
OCCUPATIONAL EXPOSURE LIMITS |
---|
ENVIRONMENT |
---|
NOTES |
---|
The symptoms of asthma often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential. Insufficient data are available on the effect of this substance on human health, therefore utmost care must be taken. |
ADDITIONAL INFORMATION | ||
---|---|---|
EC Classification Note: C; Symbol: Xn; R: 41-42/43; S: (2)-22-24-26-37/39 |
All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material. | |